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This study describes a novel approach for monitoring noncovalent interactions in solution by
electrospray mass spectrometry (ESI-MS). The technique is based on measurements of analyte
diffusion in solution. Diffusion coefficients of a target macromolecule and a potential low
molecular weight binding partner are determined by measuring the spread of an initially
sharp boundary between two solutions of different concentration in a laminar flow tube
(Taylor dispersion), as described in Rapid Commun. Mass Spectrom. 2002, 16, 1454–1462. In the
absence of noncovalent interactions, the measured ESI-MS dispersion profiles are expected to
show a gradual transition for the macromolecule and a steep transition for the low molecular
weight compound. However, if the two analytes form a noncovalent complex in solution the
dispersion profiles of the two species will be very similar, since the translational diffusion of
the small compound is determined by the slow Brownian motion of the macromolecule. In
contrast to conventional ESI-MS-based techniques for studying noncovalent complexes, this
approach does not rely on the preservation of solution-phase interactions in the gas phase. On
the contrary, “harsh” conditions at the ion source are required to disrupt any potential gas-
phase interactions between the two species, such that their dispersion profiles can be
monitored separately. The viability of this technique is demonstrated in studies on noncova-
lent heme–protein interactions in myoglobin. Tight noncovalent binding is observed in
solutions of pH 10, both in the absence and in the presence of 30% acetonitrile. In contrast, a
significant disruption of the noncovalent interactions is seen at an acetonitrile content of 50%.
Under these conditions, the diffusion coefficient of heme in the presence of myoglobin is only
slightly lower than that of heme in a protein-free solution. A breakdown of the noncovalent
interactions is also observed in aqueous solution of pH 2.4, where myoglobin is known to
adopt an acid-unfolded conformation. (J Am Soc Mass Spectrom 2003, 14, 430–441) © 2003
American Society for Mass Spectrometry
Numerous physiological processes are mediatedby noncovalent interactions involving biologi-cal macromolecules; examples include signal-
ing and regulation, immune response, protein biosyn-
thesis, and enzyme catalysis. Many drugs act by
noncovalently binding to proteins or other biopoly-
mers, often mimicking structural features of naturally
occurring ligands [1]. Experimental methods capable of
monitoring these interactions are of great importance.
Of particular interest is the identification of high-affin-
ity ligands for macromolecular drug targets in high-
throughput screening tests of compound libraries [2, 3].
Noncovalent interactions between potential ligands
and biological macromolecules can be monitored by
studying the translational diffusion of these analytes in
bulk solution. The diffusion coefficient D is determined





where k is the Boltzmann constant, T is the temperature,
and  is the solution viscosity. Small molecules diffuse
rapidly, whereas bigger molecules have larger Stokes
radii and therefore diffuse more slowly. The binding of
a small ligand to a macromolecule will significantly
reduce the diffusion rate of the ligand. This idea pro-
vides the basis for measurements of noncovalent ligan-
d–macromolecule interactions by pulsed field gradient
NMR [4–11] and fluorescence correlation spectroscopy
[12–14]. In a similar fashion, fluorescence polarization
measurements rely on changes of the rotational diffu-
sion coefficient upon complex formation [15]. Although
these diffusion-based techniques are currently the most
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powerful tools for the high-throughput screening of
combinatorial libraries [3], they are associated with a
number of problems. The ability to study complex
mixtures by NMR spectroscopy is limited by the diffi-
culty of identifying unique resonances for compounds
with similar structures [2]. Another difficulty is the
relatively low sensitivity of NMR measurements, which
often requires analyte concentrations in the millimolar
range. Especially for protein solutions, nonspecific ag-
gregation can occur under such conditions [16]. Fluo-
rescence-based methods are far more sensitive but often
require chemically labeled compounds. Other tech-
niques, such as affinity chromatography [17] or surface
plasmon resonance assays [18–21] are relatively time-
consuming because they involve the chemical immobi-
lization of compounds on solid surfaces.
Electrospray ionization mass spectrometry (ESI-MS)
represents a rapid, sensitive, and highly selective alter-
native for monitoring noncovalent interactions [22, 23].
Most studies that use this approach rely on the ability of
ESI to transfer noncovalent solution-phase assemblies
into the gas phase. Numerous studies in the literature
have confirmed the validity of this strategy, especially
for experiments on protein–protein and protein–ligand
interactions (for reviews see [24–30]). However, it is
well known that the presence of noncovalent complexes
in solution is not always correlated with the observation
of the corresponding species in the mass spectrum.
False-negative results are obtained when solution phase
complexes dissociate prior to detection. Noncovalent
binding partners that are held together primarily by
hydrophobic interactions are thought to be particularly
prone to dissociation during ESI, whereas electrostatic
complexes are often considered to be more stable [31–
33]. However, extensive dissociation during ESI is also
observed for some electrostatically stabilized com-
plexes, even under the most gentle ionization condi-
tions [34]. ESI-MS can also produce false-positive re-
sults, i.e., some analytes tend to form noncovalent
gas-phase assemblies during ESI, despite the nonexist-
ence of the corresponding complexes in solution [35,
36]. Hu et al. have demonstrated that the nonspecific
binding of metal ions to proteins can be a severe
problem when the ionization conditions are not chosen
properly [37]. These considerations imply that the pres-
ence or absence of noncovalent complex ions in an ESI
mass spectrum does not necessarily allow conclusions
to be drawn regarding specific solution phase interac-
tions. Control experiments are often required to rule out
false-positive or false-negative scenarios [24, 38, 39]. It
appears that these issues are at least partly responsible
for the limited acceptance of ESI-MS as a general tool
for “mix and measure” experiments in the context of
high-throughput screening tests [3]. The development
of alternative MS-based techniques is therefore an area
of great interest [40].
In this work, we present a novel ESI-MS approach
for the detection of noncovalent ligand–macromolecule
interactions that does not rely on the stability of these
complexes in the gas phase. Instead, it is based on
measurements of analyte diffusion in solution. The
viability of this approach is explored in studies on
noncovalent heme–protein interactions in myoglobin
(Mb) under different solvent conditions. In native holo-
myoglobin (hMb) the protein adopts a largely spherical
tertiary structure and forms a binding pocket into
which a heme group (iron protoporphyrin IX) is non-
covalently bound. Heme binding occurs through van
der Waals and hydrophobic interactions, coordination
of the central heme iron with His-93, and hydrogen
bonds involving the two heme propionate groups [41].
Under native conditions, this noncovalent complex is
extremely stable, having a dissociation constant on the
order of 1014 M [42]. Katta and Chait were the first to
demonstrate that intact hMb can be directly observed
by ESI-MS [23]. Addition of denaturants such as acid,
base or organic cosolvents can induce protein unfolding
and disruption of the native heme–protein interactions,
thus generating apo-myoglobin (aMb) and free heme.
The solution-phase transitions from hMb to aMb and
vice versa have been extensively studied, both optically
[43–45] and by ESI-MS [29, 39, 46–51]. The results of
this work demonstrate that diffusion measurements by
ESI-MS are a sensitive method for probing noncovalent
heme–protein interactions in solution.
Experimental
Chemicals
Horse skeletal muscle ferri-myoglobin, equine hemin
chloride, and piperidine were purchased from Sigma
(St. Louis, MO). Glass-distilled acetonitrile was ob-
tained from Caledon Laboratories Ltd. (Georgetown,
ON). Glacial acetic acid and HPLC-grade methanol
were products of Fisher Scientific (Nepean, ON). All
chemicals were used without further purification. Solu-
tions were prepared in freshly distilled water prepuri-
fied by reverse osmosis. Solution pH values were mea-
sured using an accumet pH meter (Fisher Scientific).
Piperidine and acetic acid were used to adjust the pH of
basic and acidic solutions, respectively. Percent compo-
sitions are reported on a volume/volume basis. All
protein solutions were prepared by using lyophilized
hMb, thus automatically ensuring a molar heme:protein
ratio of 1:1.
Optical Spectroscopy and ESI-MS
Absorption spectra of 5 M Mb solutions were recorded
on a Cary 100 spectrophotometer (Varian, Mississauga,
ON). Fluorescence emission spectra of 5 M Mb solu-
tions were measured on a Spex Fluorolog 3 fluorimeter
(Instruments S.A., Edison, NJ) using an excitation
wavelength of 280 nm. The reported fluorescence inten-
sities correspond to those measured at an emission
wavelength of 342 nm. Circular dichroism (CD) spectra
were recorded on a Jasco J-810 spectropolarimeter (Eas-
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ton, MD) using a 0.1 cm path length cuvette. For the
wavelength range between 190 and 250 nm, 15 M
myoglobin solutions were used, for the range between
250 and 320 nm the protein concentration was increased
to 50 M. ESI mass spectra of Mb at pH 10 were
recorded on an API 365 triple quadrupole mass spec-
trometer (Sciex, Concord, ON) using “soft” ionization
conditions (orifice potential 10 V, ring potential 120
V, skimmer potential  0 V), at a liquid flow rate of 5
L/min and a protein concentration of 10 M. For all
MS experiments described in this study, ions were
generated by pneumatically-assisted ESI (“ion spray”)
in the positive ion mode. Deconvoluted mass distribu-
tions were generated by using the software package
BioMultiView (Sciex, Concord, ON).
Diffusion Measurements
Dispersion profiles were recorded as described [52].
Briefly, a syringe connected to an inlet tube is employed
to fill the laminar flow tube with solution containing of
5 M analyte (Mb or heme). A sliding block mechanism
is then used to push the inlet tube out of alignment with
the laminar flow tube, such that the inlet tube can be
filled with 10 M analyte solution without disturbing
the contents of the flow tube. Upon realigning the tubes,
a sharp boundary is created between the two solutions
at the start of the flow tube. At time t  0, a syringe
pump (Harvard Apparatus, South Nattick, MA) starts
delivering 10 M analyte solution into the flow tube at
a flow rate of 5 L/min. The addition of 5 M analyte
to the initial solvent in the flow tube is a precautionary
measure to prevent possible artifacts due to wall ad-
sorption processes.
The laminar flow tube used consists of Teflon and
has an i.d. of 258.2 m (Upchurch, Oak Harbor, WA).
Slightly different flow tube lengths around 3 m were
used for individual experiments. After passing through
the flow tube, the solution is mixed with a makeup
solvent at 5 L/min for a total flow rate of 10 L/min
at the ion source. Different solvent systems were em-
ployed to optimize the signal stability for each set of
conditions. Acetonitrile-containing analyte solutions
were mixed with a solvent composed of 50% water, 30%
acetonitrile, and 20% acetic acid. For aqueous solutions
at pH 10, a makeup solvent of 80% methanol and 20%
acetic acid was used; for myoglobin in water at pH 2.4,
the makeup solvent composition was 95% methanol
and 5% acetic acid. Dispersion profiles were generated
by recording the intensities of heme (m/z 616.2) and
aMb17 (m/z 998.2) as a function of time. This was done
by selected ion monitoring on a Sciex “Toby” single-
quadrupole mass spectrometer (orifice-skimmer poten-
tial difference  100 V). Diffusion coefficients of heme
and protein were determined by fitting the measured
dispersion profiles based on the theoretical expression
given in eq 17 of reference [52]. Each reported diffusion
coefficient represents an average of around ten inde-
pendent measurements, errors correspond to one stan-
dard deviation. Solution viscosities had to be deter-
mined for the calculation of Stokes radii. These
measurements were performed by using a Cannon-
Ubelholde capillary viscometer (VWR Canlab, Missis-
sauga, ON) which allows viscosities to be determined
with an error of less than 2%. For aqueous solutions of
pH 10 in the presence of 0, 30, and 50% acetonitrile, the
viscosities were determined to be 8.97  104 kg m1
s1, 9.53 104 kg m1 s1, and 8.29 104 kg m1 s1,
respectively. For an aqueous solution of 5% acetic acid
a viscosity of 9.79  104 kg m1 s1 was measured.
The viscosity changes observed upon addition of 10 M
Mb or heme to these solutions were insignificant. All
experiments were carried out at room temperature (22
 1° C).
Results and Discussion
Optical Studies and ESI Mass Spectra
In an initial set of experiments, the effects of acetonitrile
on the Mb structure and on the noncovalent heme–
protein interactions were studied by optical spectros-
copy (Figure 1). Because the solubility of free heme at
acidic and near-neutral pH is very limited, these studies
were carried out at pH 10. The same pH was used for
the ESI-MS experiments described below. In the ab-
sence of organic cosolvents, the protein adopts a tightly
folded structure at pH 10, with the heme group seated
in the binding pocket (see [39, 51] and references
therein).
Circular dichroism (CD) spectroscopy was used to
monitor changes of the polypeptide structure. The CD
signal measured at 222 nm, which is indicative of the
-helical content [53–55], changed from15.1 103 deg
Figure 1. Acetonitrile-induced denaturation of myoglobin at pH
10 monitored by optical spectroscopy. Arrows labeled a, b, c
indicate the solvent conditions used in subsequent ESI-MS exper-
iments. Filled circles: Tryptophan fluorescence monitored at 342
nm; filled squares: heme absorption monitored at 409 nm; open
circles: ellipticity at 222 nm, measured by circular dichroism
spectroscopy; open squares: ellipticity at 266 nm. All four curves
have been normalized to unity.
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cm2 dmol1 in the absence of acetonitrile to9.77 103
deg cm2 dmol1 in 55% acetonitrile, with a sharp
transition centered around 33% acetonitrile. These data
show that acetonitrile induces a substantial collapse of
the Mb helical structure. A similar transition was seen
in the near-UV region at 266 nm, where the ellipticity
changed from 0.38  103 deg cm2 dmol1 to 0.31  103
deg cm2 dmol1, thus indicating a significant break-
down of the protein’s tertiary structure [56, 57]. The
solvent accessibility of the heme group can be probed
by absorbance changes in the wavelength range around
400 nm (Soret region). A marked decrease in the ab-
sorption at 409 nm indicates that the heme group
becomes exposed to the solvent upon unfolding at high
acetonitrile concentrations [58–62]. Also, measure-
ments of the tryptophan fluorescence provide a sensi-
tive probe for monitoring heme–protein interactions in
Mb. In native Mb, the fluorescence from Trp14 and, to a
lesser degree, from Trp7 is quenched because of reso-
nance energy transfer to the heme group [61–63]. The
drastic increase of the relative Trp fluorescence inten-
sity observed at high acetonitrile concentrations sug-
gests that denaturation is accompanied by a substantial
increase of the heme-tryptophan distances.
In summary, the optical data depicted in Figure 1
show that the addition of acetonitrile to hMb at pH 10
induces protein unfolding, and leads to a significant
disruption of the heme–protein interactions. All four
optical probes show similar unfolding curves, with
midpoints around an acetonitrile content of 33%. This
suggests that the denaturation of Mb under these con-
ditions is a cooperative (two-state) process. However,
the occurrence of folding intermediates or intermediate
modes of heme binding cannot be totally ruled out [64].
It seems possible that even at high acetonitrile concen-
trations some residual heme–protein interactions per-
sist [62]. Evidence for interactions of this kind in dena-
tured Mb has previously been obtained by vibrational
spectroscopy, albeit under different solvent conditions
[65]. The ESI-MS data presented below indicate that
weakly associated complexes between unfolded Mb
and heme may also persist under the conditions of the
current study.
The three arrows in Figure 1 mark the acetonitrile
concentrations that were used in subsequent ESI-MS
experiments; they are (1) 0% acetonitrile, corresponding
to native (or native-like) myoglobin with the heme
group firmly attached, (2) 30% acetonitrile, correspond-
ing to the onset of denaturation, and (3) 50% acetoni-
trile, corresponding to unfolded myoglobin, under con-
ditions where the native heme–protein interactions are
significantly disrupted. ESI mass spectra corresponding
to these solvent conditions are depicted in Figure 2. The
orifice-skimmer potential difference in the ion sampling
interface of the mass spectrometer was chosen as low as
possible for these experiments (see the Experimental
section), to minimize possible fragmentation of the
heme–protein complex in the gas phase [48, 66]. As
expected, the spectrum shown in Figure 2a (0% aceto-
nitrile) exclusively shows hMb ions in relatively low
charge states (around hMb10), which is consistent with
the tightly folded conformation of the intact heme–
protein complex in solution [23, 39, 46, 47, 49–51]. The
deconvoluted mass distribution obtained from this
spectrum shows a maximum at 17564 Da, which is in
good agreement with the mass expected for the intact
heme–protein complex (17568 Da). The spectrum de-
picted in Figure 2b (30% acetonitrile) shows a mixture
of hMb and aMb ions, the latter ones being the predom-
inant species. This spectrum is shifted to slightly higher
charge states and shows aMb11 as the most abundant
ion. Close inspection reveals the presence of a third
species, which corresponds to Mb with two heme
groups attached. Previous studies strongly suggest that
these ions reflect the presence of solution-phase pro-
teins that are bound to heme dimers [39, 51]. The
deconvoluted mass distribution in Figure 2b shows
three major peaks, corresponding to aMb (16950 Da),
hMb, and Mb with two heme groups (18181 Da). The
masses measured for aMb and for the two-heme species
are in good agreement with the expected values of
16952 Da and 18184 Da, respectively.
Surprisingly, the ESI mass spectrum of Mb recorded
in the presence of 50% acetonitrile (Figure 2c) looks very
similar to that obtained at 30% acetonitrile. Based on the
optical data discussed above, the contribution of aMb
ions would be expected to be much higher at 50%
acetonitrile. The significant changes in the nature of the
heme–protein interactions, taking place between 30 and
50% acetonitrile, are not reflected in the ESI mass
spectra. Qualitatively similar observations have been
reported previously, e.g., for acyl CoA binding protein,
where complexes representing vastly different solution-
phase binding affinities resulted in virtually the same
ESI mass spectra [31]. The reasons underlying this lack
of correlation between solution-phase and gas-phase
abundance are not clear. In the present case, this effect
could be rationalized by assuming different relative
ionization efficiencies of solution-phase hMb and aMb
for the different solvent conditions used. However,
without further experimental evidence this explanation
remains speculative.
Diffusion Studies
We previously introduced a method for measuring
analyte diffusion coefficients by ESI-MS [52]. ESI-MS is
used to monitor the Taylor dispersion of an initially
sharp boundary between two analyte solutions of dif-
ferent concentration in a laminar flow tube [67–72].
Under laminar flow conditions, the velocity profile in a
circular tube is given by
vr  vmax1  r2R2 (2)
where R and r are the inner radius and distance from
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the center of the tube, respectively. Liquid at the cen-
terline (r  0) moves with the maximum velocity vmax,
which is twice the average flow velocity v, while the
liquid at the tube wall (r  R) is stationary. Diffusion
experiments are carried out by initially filling a flow
tube of length l with dilute analyte solution. One end of
the tube is connected to the ESI source of the mass
spectrometer, whereas the other end is connected to a
reservoir of more concentrated analyte solution. At time
t  0, a pump starts delivering this more concentrated
solution into the flow tube, and the ESI mass spectrom-
eter starts monitoring the “dispersion profile”, i.e., the
signal intensity as a function of time. The profile ex-
pected based on eq 2 is depicted in Figure 3a. It shows
a low signal intensity, until the more concentrated
solution starts reaching the end of the tube at t l/vmax.
Subsequently, the intensity increases asymptotically to
a maximum value. This scenario does not take into
account analyte diffusion which constantly changes the
radial position of individual molecules and causes them
to exchange between zones of higher and lower flow
velocity, thus counteracting the dispersion caused by
the laminar velocity profile. If this exchange is rapid
(i.e., for large values of D), all molecules tend to travel
with roughly the same average velocity v  vmax/2,
thus leading to a dispersion profile that shows a steep
transition around t  l/v. For smaller values of D, this
averaging effect is less pronounced, and therefore the
corresponding transitions will not be as steep. Under
typical operating conditions, only radial diffusion has
to be taken into account, i.e., the contribution of diffu-
sion along the tube is completely negligible [52, 67].
Now we will consider the case where the analyte
solution represents a mixture of a macromolecular
species and a low molecular weight compound. For
reasons of simplicity it is assumed that the concentra-
tions of the two analytes are identical. In the absence of
noncovalent solution-phase interactions, the diffusion
of the two solutes is independent. Therefore, a steep
dispersion profile will be seen for the small molecule,
whereas the macromolecule will exhibit a more gradual
transition (Figure 3b). However, if the two analytes
form a noncovalent complex, the diffusion behavior of
both species will be determined by the slow Brownian
Figure 2. ESI mass spectra (left hand side panels) of myoglobin recorded at pH 10 in (a) aqueous
solution (0% acetonitrile); (b) 30% acetonitrile; (c) 50% acetonitrile. Notation: a, apomyoglobin (protein
ions without heme group); h, holomyoglobin (protein ions with heme group attached). Peaks labeled
with asterisks correspond to myoglobin with two heme groups attached. Also indicated are the charge
states of selected ions. Deconvoluted mass distributions are shown in the panels on the right hand
side.
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motion of the macromolecule. In other words, noncova-
lent binding will drastically change the dispersion profile of
the small molecule. A tightly bound ligand will exhibit
the same profile as the macromolecule (Figure 3c). This
experimental strategy requires the conditions at the ion
source to be harsh enough to ensure that noncovalent
binding does not persist in the gas phase, such that both
species can be monitored individually.
To assess the viability of the described diffusion
approach we studied the noncovalent heme–protein
interactions in myoglobin under the conditions used
above, i.e., in aqueous solutions of different acetonitrile
content at pH 10. For measuring ESI-MS dispersion
profiles, all Mb solutions were mixed with an acetic
acid-containing makeup solvent after passing through
the laminar flow tube. In all cases, the final pH after
mixing was around 2.4, which induces protein unfold-
ing and the disruption of the solution-phase heme–Mb
interactions [50, 73]. To promote the dissociation of
possible residual hMb ions in the gas phase, relatively
harsh voltage settings were used in the ion sampling
interface of the mass spectrometer (see the Experimen-
tal section). Mass spectra recorded under these condi-
tions are dominated by highly charged aMb ions, re-
gardless of the solvent environment in the flow tube
(Figure 4). The spectra show aMb ions in high charge
states, with a maximum around aMb19 which is typical
for acid-unfolded Mb [23, 39, 46, 47, 49–51] (Figure 4).
In addition, a strong signal due to free heme is ob-
served. We attribute the relatively noisy baseline of
spectra recorded under these conditions to the substan-
tial salt content of the solutions, which had been acidi-
fied from 10 to 2.4 pH. A number of minor peaks
observed at low m/z may correspond to protein frag-
ments that were generated by collision-induced disso-
ciation.
Dispersion profiles of heme and protein were gener-
ated by monitoring the intensities of heme and aMb17
as a function of time. Diffusion coefficients were deter-
mined from the measured profiles as described in the
Experimental section [52]. For each of the three aceto-
nitrile concentrations, control experiments were carried
Figure 3. Simulated ESI-MS dispersion profiles, representing the
signal intensity of selected analytes at the end of a laminar flow
tube under different conditions. (a) Dispersion profile expected for
a single analyte in the absence of diffusion, i.e., D  0. (b)
Dispersion profiles expected for a macromolecule (D  1  1010
m2/s, solid curve), and a small molecule (D  10  1010 m2/s,
dashed curve). It is assumed that the two analytes do not interact
in solution. (c) Dispersion profiles as in (b), but under the
assumption of tight noncovalent binding between the two ana-
lytes. Under these conditions the profiles measured for the two
species will be identical (for the purpose of presentation, one of
the profiles has been slightly shifted). Parameters used: Tube
length l  3 m, tube radius R  129.1 m, flow rate  5 L/min
(corresponding to vmax  3.18  10
3 m/s). The dispersion profile
in panel (a) has been calculated based on eq 19 in reference [52], all
the other profiles have been calculated based on eq 17 from the
same reference. For simplicity, all dispersion profiles have been
normalized to unity. Further explanations are given in the text.
Figure 4. ESI mass spectrum of myoglobin recorded after addi-
tion of a makeup solvent to the protein solution in the laminar
flow tube (see text). Solution conditions at the source: 30%
acetonitrile, 10% acetic acid, pH 2.4 (the initial pH before mixing
was 10.0). For notation see the caption of Figure 3. Intensities of
ions marked bold and underlined, corresponding to heme and
[aMb  17H]17, were monitored in subsequent diffusion exper-
iments. Note that the x-axis in this figure is scaled differently from
that in Figure 3.
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out to determine the diffusion coefficient of heme in the
absence of Mb. Readers are reminded that the steepness
of the measured dispersion profile increases with in-
creasing D. Figure 5a shows profiles recorded for flow
tube conditions of pH 10 and 0% acetonitrile. Protein
and heme show virtually the same profiles with diffu-
sion coefficients of (1.6  0.2)  1010 m2 s1 and (1.6 
0.1)  1010 m2 s1, respectively. This finding is consis-
tent with the known tight noncovalent heme–protein
interactions under these solvent conditions. A signifi-
cantly higher diffusion coefficient of (3.1  0.2)  1010
m2 s1 was measured for heme in the absence of Mb,
thus confirming that noncovalent binding to the protein
does indeed reduce the heme diffusion rate.
The addition of 30% acetonitrile to the solution
slightly decreases the diffusion coefficient of the protein
to (1.3  0.1)  1010 m2 s1 (Figure 5b). Within
experimental error, this is identical to the diffusion
coefficient measured for heme in the Mb solution,
which shows that heme and protein remain nonco-
valently associated under these conditions. Again, a
significantly higher value of D, (3.1  0.1)  1010 m2
s1, was measured for heme in a protein-free solution.
In contrast, the dispersion profiles recorded in the
presence of 50% acetonitrile point to a significant de-
crease in the strength of the noncovalent heme–protein
interactions (Figure 5c). Under these conditions, heme
in Mb solution shows a diffusion coefficient of (3.8 
0.3)  1010 m2 s1, which is substantially higher than
the value of (1.0  0.2)  1010 m2 s1 measured for the
protein. However, the diffusion coefficient of heme in
the Mb solution is still somewhat lower than the value
of (4.7  0.6)  1010 m2 s1 that was found in the
absence of protein. Taken together, these findings sug-
gest that the heme–protein interactions in 50% acetoni-
trile are significantly disrupted, but that some residual
binding may persist. The latter is in line with the
observation of hMb ions in the ESI mass spectrum of
Mb recorded under these solvent conditions (Figure 2c).
Diffusion measurements on Mb were also carried out
by using an aqueous solution of 5% acetic acid (pH 2.4)
as flow tube solvent. At this pH, the protein is known to
adopt an extensively unfolded conformation in solution
[16]. ESI mass spectra recorded under these conditions
closely resemble that depicted in Figure 4, with aMb19
as the most intense protein ion (data not shown). From
Figure 5. ESI-MS dispersion profiles recorded for protein (first column) and heme (second column)
in solutions of myoglobin at pH 10. The third column shows dispersion profiles recorded for heme in
protein-free solutions. The experiments were carried out in the presence of (a) 0% acetonitrile, (b) 30%
acetonitrile, and (c) 50% acetonitrile. Solid lines are fits to the experimental data according to eq 17 in
reference [52]. The diffusion coefficients determined from these fits, in units of 1010 m2 s1, are
indicated in each panel.
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the measured dispersion profiles, the diffusion coeffi-
cient of the protein was determined to be (0.42  0.01)
 1010 m2 s1 (Figure 6a). This value is lower than for
any other solvent condition used in this work. The
dispersion profiles of the heme group (Figure 6b) could
not be described by the sigmoidal model function that
was used for the other profiles. As a consequence, the
diffusion coefficient of heme could not be determined in
this experiment. Qualitatively, the heme dispersion
profile resembles that shown in Figure 3a, which was
calculated based on the assumption of no diffusion at
all (note the signal onset around t  l/vmax  940 s, in
Figures 3a and 6b). We ascribe this effect to the known
tendency of heme to undergo extensive aggregation at
acidic pH (see [39, 51] and references therein). Presum-
ably, the Stokes radii of these aggregates are large
enough to substantially suppress diffusion on the ex-
perimental time scale of 	2500 s. The observation of a
totally different diffusion behavior for heme and pro-
tein clearly indicates that noncovalent interactions be-
tween the two species are extremely weak or nonexist-
ent for these acidic conditions. This reflects the fact that
tight heme–protein interactions in Mb require the bind-
ing pocket to be in a native-like conformation, a condi-
tion that is not met for the acid-denatured protein at pH
2.4 [16]. Unfortunately, the limited heme solubility at
acidic pH precluded diffusion measurements in the
absence of protein in this set of experiments.
Stokes Radii
Based on the measured diffusion coefficients, the Stokes
radii RS of heme and protein can be calculated from eq
1 for the various flow tube solvent conditions used
(Figure 7). The RS values allow a direct comparison of
analyte “size”, without being obscured by the different
solvent viscosities of the individual experiments [74]. In
solutions of 0 and 30% acetonitrile content at pH 10, the
RS values of heme in Mb solution are close to those of
the protein, which reflects the fact that the two species
form a stable noncovalent complex. In contrast, heme in
Mb solution and in the presence of 50% acetonitrile has
a Stokes radius close to that measured in a protein-free
environment, thus indicating the disruption of the
noncovalent heme–protein interactions. The Stokes ra-
dius of (1.6  0.2) nm that was measured for tightly
folded hMb is slightly lower than the value of 2.2 nm
that has previously been determined for the native
apoprotein by size-exclusion chromatography [75]. This
is consistent with the fact that hMb under native
conditions has a more compact conformation than aMb
[16, 76]. Addition of 50% acetonitrile moderately in-
creases the RS value of the protein to (2.6  0.4) nm,
thus indicating a somewhat more expanded conforma-
tion. A dramatic increase to (5.2  0.1) nm is seen at pH
2.4, where Mb is known to be extensively unfolded [16].
It is interesting to consider the relationship between
the RS values measured for the protein, and the ESI
mass spectra recorded under the corresponding solvent
conditions. The addition of acetonitrile to Mb solutions
at pH 10 induces a slight shift of the mass spectrum to
higher charge states (Figure 2). In contrast, a more
dramatic shift is seen in the spectrum of the acid-
unfolded protein at pH 2.4 (data not shown; the ob-
served charge state distribution is virtually identical to
that depicted in Figure 4). These observations are in line
with the well known fact that the ESI charge state
distribution represents a sensitive probe of protein
conformational changes. It is generally accepted that
protein unfolding in solution leads to the formation of
more highly charged protein ions in positive-ion ESI
[77–83]. However, the physical basis of this phenome-
non is still a matter of debate [23, 84, 85]. According to
one hypothesis, a major determinant of the ESI charge
state distribution is the “compactness” of a protein in
solution [51, 83, 86–88]. This notion is compatible with
the data presented here. The Stokes radius is a measure
of the volume occupied by a protein [74], and there is a
qualitative correlation between the measured RS values,
Figure 6. ESI-MS dispersion profiles recorded for protein (a) and heme (b) in a solution of myoglobin
at pH 2.4. Note the different time scale compared to Figure 5. For further explanation see text, and the
caption of Figure 5.
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and the corresponding shifts seen in the ESI charge state
distribution of the protein.
When comparing the Stokes radii of heme measured
in protein-free solution, it is noted that a somewhat
lower RS value is observed in 50% acetonitrile com-
pared to experiments that were carried out with 0 and
30% acetonitrile. Heme is moderately soluble under all
of these conditions. However, it probably is not a
monomeric species in solution but instead forms small
aggregates consisting of a few molecules. Owing to its
hydrophobicity, the solubility of heme is epected to
increase as the percentage of acetonitrile in solution is
raised, thus decreasing the average aggregate size [89].
This effect could provide an explanation for the trend in
the measured heme Stokes radii.
Conclusions
In this work we have presented a novel ESI-MS-based
technique for monitoring noncovalent ligand–macro-
molecule interactions in solution. Our approach does
not rely on the preservation of noncovalent complexes
in the gas phase, instead it is based on measurements of
analyte diffusion behavior in solution. When a small
ligand noncovalently binds to a macromolecule, both
analytes will essentially show the same diffusion behav-
ior, which will be determined by the slow Brownian
motion of the larger species. For these diffusion studies,
any existing complexes are deliberately disrupted im-
mediately prior to ESI, in order to allow the indepen-
dent measurement of both signal intensities. This can be
achieved through a combination of “harsh” decluster-
ing voltages in the ion sampling interface of the mass
spectrometer, and through the addition of denaturing
“ESI friendly” co-solvents, such as volatile acids and
organic liquids. As a convenient side-effect, this mea-
sure will often improve the signal intensity and stabil-
ity, especially in cases where aqueous solutions of
near-neutral pH are used in the flow tube. In the
present case, this technique was applied to study heme–
protein interactions in Mb under different solvent con-
ditions. Optical spectroscopy clearly indicates signifi-
cant changes in the nature of the noncovalent
interactions between 30 and 50% acetonitrile content.
Surprisingly, ESI mass spectra recorded under these
conditions have essentially the same appearance. In
contrast, the breakdown of the heme–protein interac-
tions is clearly apparent in the measured ESI-MS dis-
persion profiles.
To minimize the time and the amount of sample
required for the approach presented in this work, it will
be necessary to reduce the dimensions of the laminar
flow tube; possibly this could be done by using mi-
crofluidic chip technology [90]. The applicability of
ESI-MS-based diffusion measurements as a tool for
high-throughput binding assays remains to be evalu-
ated. As a first step in this direction, we are currently
testing the viability of this approach in experiments
Figure 7. Stokes radii RS of myoglobin and heme, calculated from eq 1 based on the diffusion
coefficients given in Figures 5 and 6 for the solution conditions indicated. Problems with heme
solubility precluded the determination of heme RS values at pH 2.4 (see text).
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involving receptor proteins in the presence of multiple
potential ligands representing different binding affini-
ties.
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